Purple Biotech PPBT
NASDAQ PPBT
$1.52 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Acquisitions (2023)

Updated

Purple Biotech's Acquisitions was -$3.55 million in FY2023.

Analysis

Purple Biotech (PPBT) Acquisitions (2023) Analysis & Trends

  • The FY2023 figure marks the highest annual Acquisitions since FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -17.24 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -23.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.21 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Purple Biotech 249,214.64 191,214.64 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -3.55 Mn
API Access

Purple Biotech Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=PPBT&period=max&api_key=YOUR_API_KEY